Investors
Abingworth
Abingworth is an investment firm dedicated to the life sciences sector on both sides of the Atlantic. The company invests across all stages of development, including early-stage as well as public companies. Abingworth has provided backing for more than 100 unquoted life science businesses.
Over 70% of these have gone public or have merged or been acquired. Abingworth has funds under management of more than $1.25 billion. Founded in 1973, Abingworth has offices in London, Cambridge (UK), Menlo Park (California) and Boston.
US Offices
3000 Sand Hill Road 890 Winter Street
Bldg. 4, Suite 135 First Floor
Menlo Park Waltham
CA 94025 MA 02451
phone +1 650 926 0600 phone: +1 781 466 8800
Fax: +1 650 926 9782 Fax: +1 781 466 8813
Malaysian Technology Development Corporation
Malaysian Technology Development Corporation Sdn Bhd (MTDC) is an agency under the Ministry of Science, Technology and Innovation (MOSTI). It was incorporated on March 10, 1992 with the focus on commercializing research results of universities and research institutions, identifying and transferring emerging and strategic technologies for adoption by industries, and encouraging the growth of technology-based enterprises in Malaysia. To facilitate its operation, MTDC functions as an integrated venture capital company, whose role is to identify, finance and develop potential companies and strategic technology areas.
MTDC is committed to provide services to individuals, entrepreneurs and companies in the areas of technology financing, government grants, technology incubators and consultancy. These services form the core of MTDC's activities to spearhead technology development in Malaysia. MTDC's area of focus includes life sciences and biotechnology, advanced materials, photonic, renewable energy, precision engineering, advanced electronics, and services.
Malaysian Technology Development Corporation Sdn Bhd
Level 3-4, MIDF Building,
195A, Jalan Tun Razak,
50400 Kuala Lumpur
phone (603)-2161 2000
fax (603)-2163 7542
email: comms@mtdc.com.my
www.mtdc.com.my
InterWest Partners
Investing since 1979, InterWest Partners is a leading diversified venture capital firm currently investing InterWest IX, a $600 million fund. With more than $2B in capital under management, we take a long-term collaborative approach to venture funding, providing early-stage and ongoing capital, management development and access to a broad network of resources.
InterWest Partners
2710 Sand Hill Road
Second Floor
Menlo Park, CA 94025
USA
phone 650-854-8585
fax 650-854-4706
info@interwest.com
MPM Capital
MPM Capital is the world's largest dedicated investor in life sciences. With committed capital under active management of more than $2.1 billion, MPM is uniquely structured to invest globally in healthcare innovation. In addition to its BioVentures family of venture capital funds, MPM invests in the public markets through its BioEquities hedge fund. Primarily in biotechnology, but also in medical devices and biopharmaceuticals, MPM has seamlessly integrated private and public equity products to target innovation in healthcare and, thereby, deliver exceptional returns to investors. The MPM BioVentures and MPM BioEquities family of funds are two distinctly different but highly complementary investment vehicles.
MPM Capital
John Hancock Tower
200 Clarendon Street, 54th Floor
Boston, MA 02116
Phone: 617-425-9200
Fax: 617-425-9201
Email: Info@MPMCapital.com
www.MPMCapital.com
Burrill & Company
Burrill & Company is a life sciences merchant bank focused exclusively on companies involved in biotechnology, pharmaceuticals, diagnostics, devices, human healthcare and related medical technologies, nutraceuticals and wellness, agricultural biotechnology, and industrial biotechnology (biomaterials/bioprocesses) with over $500 million under management. Burrill's technical and venture investing competence spans the entire spectrum of life sciences.
Burrill & Company
One Embarcadero Center, Suite 2700
San Francisco, CA 94111-3776
Phone: 415-591-5400
Fax: 415-591-5401
burrill@b-c.com